From the Editor's desk.

OA: gold CC-BY-4.0
⚙ AI-generated summary by qwen3.7-flash+body, 2026-08-18 ⓘ

This editorial introduces the second issue of the Journal of Human Reproductive Sciences, highlighting review articles on endometriosis and ovarian cryopreservation alongside original research on impaired spermatogenesis and polycystic ovary disease.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-08-18 · read from full text ⓘ

This editorial introduces the second issue of the Journal of Human Reproductive Sciences, highlighting a stringent peer-review process that ensures the publication of high-quality and clinically relevant research. The editor specifically draws attention to two review articles, one by Ian Fraser on endometriosis and another by Dr. Balaji regarding ovarian cryopreservation for fertility preservation in cancer patients. Additionally, the issue features lead articles on impaired spermatogenesis, polycystic ovarian disease, and menstrual cycle-related mineral changes, alongside four case reports. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 1,650 characters · extracted from oa-doi-fallback · click to expand
It is my proud privilege to be writing this editorial for the second issue of Journal of Human Reproductive Sciences. It has always been my intention to provide the readers of JHRS with a varied selection of relevant and interesting articles in each issue of the general. At the outset, I must first stress that I consider all papers that reach the publication stage of this journal to be of high quality and importance. Our reviewing process is quite stringent and is a testimonial to this. The papers selected are those that we have found to be particularly interesting and we hope that perhaps you will too. The two review articles on Endometriosis by Ian Fraser of Australia and Ovarian Cryopreservation by Dr. Balaji of Singapore are both interesting and informative. Our sincere thanks to Judy Passlow, publisher of “Medicine Today” for granting us permission to reproduce the article on Endometriosis by Ian Fraser. Over the last few years, fertility preservation in cancer patients by cryostorage of ovarian tissue has become a part of clinical practice. There is however a risk that cancer cells are present in the stored tissue and that the cancer could recur after transplantation. To increase the safety of the procedure, methods to detect disease in the ovaries and malignant cells in stored tissue are indicated. Outcome in Impaired Spermatogenesis, Polycystic Ovarian Disease and Change in Serum Calcium, Manganese and Phosphorous levels in different phases of the menstrual cycle, form the lead articles for this issue along with four case reports. I do hope you will enjoy reading this issue as much as we enjoyed bringing it to you.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-04T09:26:46.659050+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Per Europe PMC